Freiburg Myeloma Workshop

Dear Colleagues,

following the practice of assembling outstanding experts at Freiburg University annually, to let them share their insights on advances in multiple myeloma (MM), we are very happy to welcome you all to the 16th MM Meeting 2025. Over the last years, remarkable advances in the field have steadily improved the outcome of patients suffering from plasma cell dyscrasias. Myeloma physicians, both in the clinic and outpatient office, face challenges as the options available add up to a whole variety of valuable treatment strategies.

"16th MM Meeting 2025 – Immune therapies in MM: Moving forward" is the title of our 2025 workshop meeting, which is a live Hybrid meeting again.

We have invited worldwide eminent authorities from the US, Austria and Germany, who will - with UKF experts plus commentary guests - share their data with us in straightforward discussion rounds.

Therewith, we will cover new treatment modalities in MM, will solve, where the future in MM evolves to, what are current, worldwide trials from the US and Europe and pending solutions needed for this disease.

Cordially looking forward to seeing you during this meeting in November 2025

 

Flash talk session | 15 - 17h

Chairs: Prof. Dr. Maria Krauth, Vienna, Dr. Michael Rassner, PD Dr. Christine Greil, Jan Kus, Dr. Henning Schäfer, UKF

Preclinical projects

1. Kirstyn Crossley | Oncostatin M as a key regulator of CD38 expression and a potential biomarker in MM

2. Michael Rassner | Personalized medicine approaches within molecular TB CCCF

3. Niloufar Mohammadkhani, Andreas Frodl, Tanja Hartmann | Bone microenvironment in MM

4. Nina Schlosser, Derya Steenbuck / Oliver Schilling | Proteomics study in healthy volunteers, multiple myeloma and amyloidosis pts: significant differences and ways for better diagnostics?

5. Jakob Neubauer | Structured radiology: Body Composition projects

Clinical projects

6. Hanna Löffler, Magdalena Braun, Heike Reinhardt | Vision of Draining the Data Swamp of ChemoCompile – Opportunities and Challenges in the Development of an Analysis Tool

7. Marie Böttger | CAR-T-cell outcome Ide-cel and Cilta-cel

8. Pauline Sauerborn | Choosing the right immunotherapy: does the use of the R-MCI influence the use of ADC, BITEs and CAR-T-cells?

9. Sina Wenger | Dental study on ONJ avoidance

10. Marius Niewald | AL-Amyloidosis screening via fat-pad biopsy and -aspiration and implication for therapy, including CAR-T cells

11. Carlotta Pietsch, Georg Herget | Do CRAB criteria predict the progression of myeloma bone disease in follow-up patients?

12. Patrick Marschner | Clinical trial update Iomedico: MM

13. Antonia Egert, Marcel Knüttel, Julian Rapp, Max Schinke, Dominik Marschner, Stephan de Bra | Index MM pts with rare MM and/or therapy-induced phenomenons: intracerebral EM MM and bilateral facial palsy after CAR-T-cells with in each review of the literature

Pause: snacks and drinks

Program 16th MM Workshop | 18 - 21h

6:00 – 6:05 pm | Welcome and Introduction
Justus Duyster | Monika Engelhardt

Session I: Tackling immunotherapies
Chair: Laura Gengenbach, Maximilian Schinke, Monika Engelhardt

6:05 – 6:30 pm | The biology of bone marrow independent disease in MM
Niels Weinhold, UK Heidelberg

6:30 – 6:55 pm | Tackling resistance to CAR-T cell therapy in MM
Andrea Schmidts, Tu Munich

6:55 – 7:10 pm | Pro/contra session: Best time to give CAR-T cells, BiTEs and ADCs: frontline, 2nd or beyond
Ralph Wäsch + Monika Engelhardt, UKF

Pause: snacks and drinks II

Session II: Novel strategies
Chair: Maria Krauth, Paul la Rosee, Ralph Wäsch

7:30 – 8:00 pm | Possibilities and challenges of immunotherapies in MM: the US perspective
Surbhi Sidana, Stanford, USA

8:00 – 8:15 pm | What to adopt for the daily routine? Comments + learning remarks
Patrick Marschner, Freiburg | Thomas Fietz, Singen | Robin Benkelmann, Konstanz | Dominik Schnerch, Villingen | Henning Pelz, Offenburg | Cornelius Miething, Freiburg |+ all virtual participants

Dr. Robin Benkelmann
Facharztpraxis für Innere Medizin, Hämatologie und Onkologie
MVZ Konstanz

Prof. Dr. Justus Duyster
Ärztlicher Direktor
Klinik für Innere Medizin I, Hämatologie, Onkologie & Stammzelltransplantation
Klinischer Direktor des Tumorzentrums Freiburg - CCCF
Universitätsklinikum Freiburg

Prof. Dr. Monika Engelhardt
Sektionsleitung Klinische Forschung
+ MM-Programm UKF
Klinik für Innere Medizin I, Hämatologie, Onkologie & Stammzelltransplantation
Universitätsklinikum Freiburg

Dr. Thomas Fietz
Praxis Singen

Dr. Laura Gengenbach
Klinik für Innere Medizin I
Universitätsklinikum Freiburg

PD Dr. Christine Greil
Klinik für Innere Medizin I, Hämatologie, Onkologie & Stammzelltransplantation
Universitätsklinikum Freiburg

Prof. Dr. Paul Graf La Rosée
Klinik für Innere Medizin II
Schwarzwald-Baar Klinikum Villingen-Schwenningen

Prof. Dr. Tanja Hartmann
Hämatologie, Onkologie & Stammzelltransplantation + CCCF
Universitätsklinikum Freiburg

Jan Kus
Klinik für Innere Medizin I
Universitätsklinikum Freiburg

Dr. Patrick Marschner
iOMEDICO

Prof. Dr. Georg Herget / Dr. Carlotta Pietsch 
Klinik für Orthopädie und Unfallchirurgie
Universitätsklinikum Freiburg

Prof. Dr. Maria Krauth
Klinische Abteilung für Hämatologie und Hämostaseologie
Universitätsklinik für Innere Medizin I
Medizinische Universität Wien

Dr. Cornelius Miething
Klinik für Innere Medizin I, Hämatologie, Onkologie
Universitätsklinikum Freiburg

PD Dr. Jakob Neubauer
Klinik für Radiologie
Universitätsklinikum Freiburg

Marius Niewald
Klinik für Innere Medizin I
Universitätsklinikum Freiburg

Dr. Michael Rassner
Klinik für Innere Medizin I
Universitätsklinikum Freiburg

Dr. Heike Reinhardt, Hanna Löffler, Magdalena Braun
Hämatologie, Onkologie
Universitätsklinikum Freiburg

Dr. Henning Pelz
Ambulantes Therapiezentrum für Hämatologie und Onkologie
Offenburg

Dr. Henning Schäfer
Klinik für Strahlenheilkunde
Universitätsklinikum Freiburg

Dr. Andrea Schmidts
Klinik und Poliklinik für Innere Medizin III
Klinikum der Technischen Universität München

PD Dr. Dominik Schnerch
Praxis Drs. Schnerch/Köchling
Villingen-Schwenningen

Dr. Surbhi Sidana
Blood and Marrow Transplantation and Cellular Therapy
Stanford University, USA

Dr. Ines Derya Steenbuck
Universitäts-Herzzentrum Klinik Kardiologie
Universitätsklinikum Freiburg

Prof. Dr. Ralph Wäsch
Sektionsleitung Medizinische Zelltherapie
+Zellforschung (SMZZ) + MM-Programm
Klinik für Innere Medizin I
Universitätsklinikum Freiburg

Dr. Niels Weinhold
Klinische und translationale Forschung Myelomzentrum Heidelberg
Innere Medizin V: Hämatologie, Onkologie und Rheumatologie
Universitätsklinikum Heidelberg

Dr. Sina Wenger
Klinik für Mund-, Kiefer- und Gesichtschirurgie
Universitätsklinikum Freiburg
 

The Myeloma Workshop 2025 is an hybrid live event. Participation is possible on site and online and is free of charge.

Online registration for on-site & online attendance will open soon. 

And if you have any questions, do not hesitate to contact us.

We thank all our sponsors for greatly supporting this meeting.

Janssen-Cilag GmbH (Johnson&Johnson Innovative Medicine) - 10.000€ for a 4sqm booth and advertising purposes
 

Organizing committee

Medical Center University of Freiburg
Department of Medicine I - Specialties: Hematology, Oncology and Stem Cell Transplantation

Hugstetter Straße 55 I 79106 Freiburg

Prof. Dr. Monika Engelhardt
Mandy-Deborah Möller
Prof. Dr. Ralph Wäsch
Sina Wenger
Stephanie Lavielle

AG Engelhardt
Sektion Klinische Forschung & ECTU MED1

CCCF
Prof. Justus Duyster, Prof. Christoph Peters and CCCF Team

Internet:
www.uniklinik-freiburg.de /medizin1
www.uniklinik.freiburg.de/cccf

Congress Organizer

Medical Center University of Freiburg
Communication Department | Event Management
Elke Bührer

Breisacher Str. 153
79110 Freiburg

+49 761 270-19210

veranstaltung@uniklinik-freiburg.de